ACI’s European Prefilled Syringes Summit will be taking place in London, UK, on the 7th – 8th September, 2016. The two day event will provide an exclusive platform for collaboration and discussion between a variety of industry perspectives including manufacturers, suppliers, academia and regulators homing in on the latest opportunities arising from new Biological Medicines. The aim is to identify potential solutions, future work programmes and productive partnerships that overcome the key regulatory challenges and facilitate minimizing risk within the supply chain promoting access to safe and effective biologicals.
Key Topics
Key Topics:
Senior management within:
Confirmed Speakers Include:
Florence Schwarzenbach, Senior Clinical Development Manager, Becton Dickinson (BD) Hadj Latreche, Combination Products (Medical Device & Drug) Methods, Process and Infrastructure Group Leader, Roche Pharmaceuticals Dr. Rene Dathe, Project Manager Medical Devices, Sanofi Thomas Fischer, Senior Quality Manager Medical Device, Novartis Mike Hrytsak, Manager, Combination Products Regulatory Affairs, Regeneron Pharmaceuticals Ian Thompson, Vice President Business Development, Ypsomed AG Janine Jamieson, Former Assessor, MHRA Fabien Roy, Senior Associate, Hogan Lovells Martin Murphy, Marketing Lead MedTech Division, Cambridge Consultants Andy Varde, Director of Research & Development, Owen Mumford David Blakey, Device Engineering Manager, GSK Joel Richard, Senior Vice President, Peptides – Head Of CMC Development, IPSEN Pharmacueticals Bastiaan Deleeuw, Head of Business Development, Oval Medical Technologies Matteo Falgari, Head of Business Development , Nipro Europe Jeremy Kooyman, Medical Device Design & Development, Cambridge Design Partnership Patrick Radermacher, Managing Director, Sterisys Sàrl Adrian Tisserand, Global Category Manager, Nemera Emmie Galilee, Head of Health & Social Care Services Unit, HSE Health And Safety Executive |
If you would like to be considered as a speaker for the event with a 20-45 minute presentation, please submit an abstract for consideration to:
Chloe Wates
Tel: +44 (0)20 3141 0638
Email: [email protected]
Nemera is a world leader in the design, development and manufacturing of drug delivery solutions for pharmaceutical, biotechnology and generics industries.
Its expertise covers several modes of delivery:
Nemera leverages decades of manufacturing and development experience in the parenteral device segment to offer patients premium products and customers a complete service. With the support of Nemera’s global centre of expertise which is composed of more than 50 engineers and experts in creative design and human factor activities, Nemera is able to drive an idea from concept all the way to high scale manufacturing.
Nemera’s balanced business model includes: full proprietary product development (such as passive safety device for prefilled syringes Safe’n’Sound®), contract manufacturing and customized solutions. This model gives flexibility to customers, being able to enter in the development and manufacturing process at any stage. Depending on their needs, pharmaceutical companies can leverage Nemera’s know-how and expertise to develop customized solutions based on either customers’ or Nemera’s intellectual property.
For more information, please visit http://www.nemera.net
Contact: [email protected]
LinkedIn: https://www.linkedin.com/company/nemera
Twitter: @Nemera_devices
STERISYS is a young and dynamic company offering an outstanding solution portfolio in two different domains: Industrial Sterilisation Equipment and Automatic Handling Systems for Pre-filled Syringes.
STERISYS is European market leader in the area of industrial sterilisation with their leading technology and advanced solutions designed for the medical devices producers and contract sterilisation organisations. STERISYS is not a mere manufacturer but a systems integrator supplying turnkey solutions. Their holistic approach towards sterilisation systems is what differentiates them from other players in the industry.
In the industrial pharmaceutical sector, STERISYS develops, markets and supplies Krysalid®, an innovative solution to resolve the problems encountered with handling, transfer and transport of nest-and-tub pre-fillable syringes.
The Krysalid® system does not focus on a specific application for automation, but in finding a global solution to handle nest-and-tub configured products. Pre-fillable systems are usually very difficult and tedious to handle manually. They are applied in multiple situations (transfer to working stations, inspection machines, terminal sterilisers, etc.) and have slightly different shapes depending on the manufacturer. The solution to all these variables is based on combining the nest-and-tub support elements with specific patented devices to facilitate the interface with both humans and robots. By using these devices, the handling operation is gentle and the products (syringes, vials) will be safe from risk.
The emergence of a new player like STERISYS in the Pre-Filled Syringes domain, in close cooperation with the syringe manufacturers, drug manufacturers and equipment suppliers, will offer a world of new possibilities to achieve the growth expectations within this industry.
ACI has put together a range of packages to suit your requirements. These range from branding options, to full scale partner solutions and can be tailored to meet your objectives and budgets.
If you are launching a new product or service and wish to gain visibility and brand recognition within your industry, contact us today!
For commercial opportunities, please contact:
Tim Rowley-Evans
+44 20 3141 0637
IPI – International Pharmaceutical Industry
IPI – was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.
Edited by our carefully selected editorial advisory panel, and extensive research network, IPI provides a proven supportive means of communication to the pharmaceutical, bio pharmaceutical, nutraceutical and medical devices industry the latest in research and technology innovations, regulatory guidelines, marketing and communication strategies which will enable them to be more efficient, bring products to market faster, reduce cost and make healthcare accessible to all.
We have established a strong presence in the US, Central Europe, Middle East, Latin America, Eastern Europe, Asia and Africa which are becoming increasingly important to the way the industry is moving forward in areas of Research and Development, Trials, Manufacturing and Technology Transfer.
Medical News Today is the largest independent medical and health news site on the web – with 10,000,000 monthly unique users it is ranked number one for medical news on all major search engines. Medical News Today is used by pharmaceutical, biotech and health organizations, advertising agencies, PR companies and vertical ad networks to deliver targeted campaigns to HCPs, patients and caregivers. To find out how Medical News Today can help you to reach the right audience contact [email protected] or visit www.medicalnewstoday.com.
Swiss Biotech Association (SBA) was founded in March 1998. Today over 210 companies are member of the growing national industry association. SBA is the industry association for small and medium-sized enterprises that are active in all areas of biotechnology. It is also a highly resprected networking platform for multinational companies active in the sector. Activities of member companies span different sectors of biotechnology including (bio-) pharmaceuticals, diagnostics, agriculture, food, environmental biotechnology, nanotech, nutrition, cosmetics, marine-oriented research and specialty chemicals. The SBA partners with the Swiss life science clusters and manages Swiss Biotech™ – the global brand for the industry.
Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology.
Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad.
PharmaVision offers a consultancy service providing high quality, due diligence research and independent, tailor made life science reports to pharmaceutical companies, competitive intelligence specialists, investment institutions and healthcare communication agencies. We develop market models to forecast the potential growth of key developmental products and technologies and assess the challenges and opportunities which surround this specialist sector. We will also undertake in-depth interviews with key opinion leaders and generate slide decks for conferences and corporate meetings. For further information visit our website www.pharmavision.co.uk or contact Cheryl on +44 (0) 1243 785496 or via email [email protected]
Colorado BioScience Association champions life science. We serve as the hub of Colorado’s thriving bioscience sector by connecting innovators to funding, infrastructure, research and talent. From promising young companies to established corporations and institutions, we provide opportunities for networking, education and professional development. We grow the bioscience workforce and lead business expansion policies to advance the industry in our state. CBSA represents more than 350 member organizations, including biotechnology, pharmaceutical, medical device, diagnostic, ag bio and mobile digital health companies, research and academic institutions and service providers.
Link: http://www.cobioscience.com/
Technology Networks has been established for over 10 years and is now the leading provider of free information services for life science professionals. This includes news, events, posters, videos, webcasts, application notes, new products, a literature search engine and product directories. The information is specifically tailored to over 30 individual communities with specific interests, all of which can be accessed through TechnologyNetworks.com.
http://www.technologynetworks.com/
Bentham Science Publishers is rendering a vital service in the quality publication of over 100 peer-reviewed print and online scientific, technical and medical journals. These titles are indexed in recognized indexing agencies, such as Science Citation Index®, Journal Citation Reports/Science Edition, MEDLINE/Index Medicus, PubMed, Scopus, Chemical Abstracts, EMBASE etc. Some of the high impact titles which enjoy a wide reach and distribution are Current Gene Therapy (Impact Factor 4.906), Current Alzheimer Research (Impact Factor 3.796), Current Medicinal Chemistry (Impact Factor 3.715), and other popular titles.
Bentham has an extensive library of eBooks in the areas of science, technology, medicine, social sciences and humanities. Bentham eBooks publishes monographs, handbooks, conference proceedings, textbooks, review volumes, biographies and autobiographies.
FarmavitaR+ is the professional network of regulatory affairs consultants. The company profiled itself to be the top service provider in regulatory affairs, in central-east and south-east Europe. We are employing a few people in Croatia and the network of associates in Czech R, Slovak R., Hungary, Serbia, Bosnia and Herzegovina, Macedonia, Bulgaria, Romania and Turkey.
Webpackaging, part of the Webpac Digital Media Group’s suite of online services, is the best global platform available for connecting packaging buyers with packaging suppliers. It is the packaging industry’s most powerful search engine scanning news, products, specifications, web sites, documents, videos, and more. The site contains 10,000+ comprehensive company portals with over one million pages of tagged content and features the 3D Design Studio, Packaging Catalogs, Packaging Maps, Packaging Trends and Innovations, Packaging Events, and more.
Webpackaging is where successful brands source packaging.
SelectScience is an independent, online review resource for the worldwide scientific community, and the fastest way to impartial, expert opinion about the latest laboratory equipment and techniques. Discover new technologies, products and trusted reviews; plus videos, application notes and the latest science news from around the world. Become a member for free today: http://www.selectscience.net/
MarketsandMarkets is a global market research organization which is also into advisory and consulting services. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
Using effective technology to automate management of large and complex data for forecasts, we provide global analysis, data and insights through unique & in-depth research, serving multi-client reports, company profiles, databases, and custom research services. These intelligence databases comprises of about 60000 reports a year, which forms one of the world’s largest intelligence resources. M&M plans to launch industry-wise and country wise market tracker for all existing research verticals.
The major industries that we cover in our market intelligence deliverables are:
Telecom & IT
Semiconductor & electronics
Chemicals
Medical Devices
Pharmaceuticals
Energy and Power
Healthcare & Life sciences
Food and Beverages
Aerospace and Defense
http://www.marketsandmarkets.com
International Journal of Biomedical Engineering and Technology
IJBET addresses cutting-edge research in the multi-disciplinary area of biomedical engineering and technology. Medical science incorporates scientific/technological advances combining to produce more accurate diagnoses, effective treatments with fewer side effects, and improved ability to prevent disease and provide superior-quality healthcare. A key field here is biomedical engineering/technology, offering a synthesis of physical, chemical, mathematical and computational sciences combined with engineering principles to enhance R&D in biology, medicine, behaviour, and health. IJBET includes the Asia-Pacific Chapter in Biomedical Wireless Technology (APC-BWT).
International Journal of Biotechnology
IJBT provides an international forum and refereed authoritative source of information in the field of Biotechnology and Biotechnics, with emphasis on management and economics, as well as the political and social issues. It aims to disseminate knowledge, provide a learned reference in the field, and establish channels of communication between academic and research experts, policy makers and executives in industry, commerce and investment institutions.
International Journal of Biomedical Nanoscience and Nanotechnology
IJBNN proposes and fosters discussion on scientific and technological investigations of nanomaterials in biology and medicine, with emphasis on their biomedical implications and impacts upon the biosphere. This perspective acknowledges the complexity of biomedical nanoscience and nanotechnology as an interface between the biomedical arena and the nanosystem.
International Journal of Healthcare Technology and Management
JHTM is a series emerging from the International Journal of Technology Management. It provides an international forum and refereed authoritative sources of information in the fields of the economics and management of technology in healthcare.
International Journal of Medical Engineering and Informatics
IJMEI promotes an understanding of the structural/functional aspects of disease mechanisms and the application of technology towards the treatment/management of such diseases. It seeks to promote interdisciplinary collaboration between those interested in the theoretical and clinical aspects of medicine and to foster the application of computers and mathematics to problems arising from medical sciences. IJMEI includes authoritative review papers, the reporting of original research, and evaluation reports of new/existing techniques and devices. Each issue also contains a comprehensive information service.
International Journal of Biomedical Nanoscience and Nanotechnology
IJBNN proposes and fosters discussion on scientific and technological investigations of nanomaterials in biology and medicine, with emphasis on their biomedical implications and impacts upon the biosphere. This perspective acknowledges the complexity of biomedical nanoscience and nanotechnology as an interface between the biomedical arena and the nanosystem.
If you would like a copy of the brochure for this conference please complete the form below and click 'submit'.